Institutions are focused on $SPCX. Retail should be focused on the proxies surrounding it. You aren't going to get a good entry on $SPCX but you can absolutely print money using it as a catalyst. And I've been explaining how for months... Retail can't easily access the IPO. 5% float means institutions get allocations first. But $SPCX qualifies for Nasdaq-100 fast-entry inclusion, so every index fund will be forced to buy it. Fund managers know the forced demand is coming. So they're already positioning ahead and actively rotating into space adjacencies right now. Here's the thing... retail can do the exact same thing. You actually have a chance to get solid entries. Now the aftermath... $SPCX is the biggest IPO in history. Every public space name suddenly looks underpriced relative to the new ~$1.75T+ benchmark. Analyst upgrades. Institutional coverage expands. Media attention amplifies. Look at $CRWV's IPO - the entire Neocloud sector ($IREN, $CIFR, $APLD, etc.) re-rated for months after. Obviously there were other catalysts as well, but it'd be unwise to think the Space sector won't. A few names that'll benefit: $ASTS $LUNR $PL $RDW $RKLB $SATL $SIDU $SPIR $UFO ETF And my most recent asymmetric position: $AMPG. Full thesis on how Amplitech is significantly undervalued relative to the rest was shared earlier. Make sure to read it. $SPCX itself should explode on debut, then could become a sell-the-news event as we've seen before. Undoubtedly, the sector will see turbulence. But the downstream chain has a longer runway because the institutional discovery, re-rating, and capital rotation continues well beyond IPO day. This is why the chain matters more than the IPO itself. Would rather be positioned in asymmetric opportunities than chase $SPCX. I'll DCA in when the dust settles.
